Scale Biosciences and Revvity's BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single CellsBusiness Wire • 11/19/24
Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent TransformationBusiness Wire • 11/18/24
Revvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical LaboratoriesBusiness Wire • 10/22/24
Revvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact ReportBusiness Wire • 10/22/24
RVTY's Latest Launch to Enable APOE Genotyping of Alzheimer's DiseaseZacks Investment Research • 10/10/24
Revvity's EUROIMMUN Launches Solution for Specific Typing of Alzheimer's Disease Associated APOE GeneBusiness Wire • 10/02/24